These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37925456)
1. Polymer composite microspheres loading Xiao L; Li Y; Geng R; Chen L; Yang P; Li M; Luo X; Yang Y; Li L; Cai H Biomater Res; 2023 Nov; 27(1):110. PubMed ID: 37925456 [TBL] [Abstract][Full Text] [Related]
2. Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy. Wu M; Zhang L; Shi K; Zhao D; Yong W; Yin L; Huang R; Wang G; Huang G; Gao M ACS Appl Mater Interfaces; 2023 Mar; 15(10):12669-12677. PubMed ID: 36854016 [TBL] [Abstract][Full Text] [Related]
3. Biodegradable Pang F; Li Y; Zhang W; Xia C; He Q; Li Z; Xiao L; Song S; Dong P; Zhou H; Shao T; Cai H; Li L Adv Healthc Mater; 2020 Jul; 9(13):e2000028. PubMed ID: 32431090 [TBL] [Abstract][Full Text] [Related]
4. Ultrastable PLGA-Coated Jin S; Huang J; Dong Y; Hu D; Sun J; Li Z; Zhong BY; Liu Z; Zhu R; Wang G Mol Pharm; 2024 Jul; 21(7):3407-3415. PubMed ID: 38822792 [TBL] [Abstract][Full Text] [Related]
5. Radioiodine-131-Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor. Jia G; Wang T; Li R; Li X; Sun G; Chen W; Peng Y; Cheng C; Yang J; Zuo C Adv Healthc Mater; 2023 Dec; 12(32):e2301559. PubMed ID: 37807421 [TBL] [Abstract][Full Text] [Related]
7. Wu X; Ge L; Shen G; He Y; Xu Z; Li D; Mu C; Zhao L; Zhang W ACS Appl Mater Interfaces; 2022 May; 14(19):21848-21859. PubMed ID: 35507826 [TBL] [Abstract][Full Text] [Related]
8. Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study. Kolligs F; Arnold D; Golfieri R; Pech M; Peynircioglu B; Pfammatter T; Ronot M; Sangro B; Schaefer N; Maleux G; Munneke G; Pereira H; Zeka B; de Jong N; Helmberger T; JHEP Rep; 2023 Feb; 5(2):100633. PubMed ID: 36593888 [TBL] [Abstract][Full Text] [Related]
9. For Hepatocellular Carcinoma Treated with Yttrium-90 Microspheres, Dose Volumetrics on Post-Treatment Bremsstrahlung SPECT/CT Predict Clinical Outcomes. Taswell CS; Studenski M; Pennix T; Stover B; Georgiou M; Venkat S; Jones P; Zikria J; Thornton L; Yechieli R; Mohan P; Portelance L; Spieler B Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765603 [TBL] [Abstract][Full Text] [Related]
10. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First De La Vega JC; Esquinas PL; Rodríguez-Rodríguez C; Bokharaei M; Moskalev I; Liu D; Saatchi K; Häfeli UO Theranostics; 2019; 9(3):868-883. PubMed ID: 30809314 [TBL] [Abstract][Full Text] [Related]
11. Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-Based versus Resin-Based Microspheres. Villalobos A; Arndt L; Cheng B; Dabbous H; Loya M; Majdalany B; Bercu Z; Kokabi N J Vasc Interv Radiol; 2023 Jul; 34(7):1226-1234. PubMed ID: 36958669 [TBL] [Abstract][Full Text] [Related]
12. Role of nanoparticles in transarterial radioembolization with glass microspheres. Talebi AS; Rajabi H; Watabe H Ann Nucl Med; 2022 May; 36(5):479-487. PubMed ID: 35199286 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of results after 112 radioembolizations with Casáns-Tormo I; Guijarro-Rosaleny J; Lluch-García P; Rodríguez-Parra H; Roselló-Keränen S; Asensio-Valero L Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(4):255-264. PubMed ID: 37269983 [TBL] [Abstract][Full Text] [Related]
14. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
16. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis. Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644 [TBL] [Abstract][Full Text] [Related]
17. Resin Versus Glass Microspheres for Van Der Gucht A; Jreige M; Denys A; Blanc-Durand P; Boubaker A; Pomoni A; Mitsakis P; Silva-Monteiro M; Gnesin S; Lalonde MN; Duran R; Prior JO; Schaefer N J Nucl Med; 2017 Aug; 58(8):1334-1340. PubMed ID: 28082436 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Preliminary Biological Evaluation of Pandey U; Subramanian S; Shaikh S; Gamre N; Kumar S; Dash A Cancer Biother Radiopharm; 2019 Jun; 34(5):306-315. PubMed ID: 31188652 [No Abstract] [Full Text] [Related]
19. Radionuclide-Labeled Microspheres for Radio-Immunotherapy of Hepatocellular Carcinoma. Yang S; Mu C; Liu T; Pei P; Shen W; Zhang Y; Wang G; Chen L; Yang K Adv Healthc Mater; 2023 Oct; 12(26):e2300944. PubMed ID: 37235739 [TBL] [Abstract][Full Text] [Related]
20. Predicting the net administered activity in Henry EC; Lopez B; Mahvash A; Thomas MA; Kappadath SC Med Phys; 2023 Nov; 50(11):7003-7015. PubMed ID: 37272198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]